Leading medical device and digital health startups will today pitch for a place on Medtech Innovator’s Accelerator Programme, which supports the development of the most promising innovations in the field. Partners, Trinity College Dublin and RCSI University of Medicine and Health Sciences, play host to the event.

Each year, MedTech Innovator – the largest accelerator in the global medical technology industry – selects the most promising medical technology startups and emerging growth companies and matches them with healthcare leaders for mentorship and support via its Accelerator Programme.

In 2023, MedTech Innovator and its partners will give out over US$1,000,000 in cash prizes as well as other awards across their programmes. Each programme has its own cohort and includes several rounds where companies gain increasing amounts of exposure to industry leaders including through online application reviews, pitch events, and audience competitions at several major industry conferences.

The event taking place today, in The Shelbourne Hotel, will feature pitches from the best-in-class medical device and digital health companies in the region. The participating companies are selected from hundreds of applicants internationally. In addition, attendees pitch to a panel of judges and have the opportunity to network with MedTech Innovator partners such as investors and key industry executives.

This event is part of the Trinity RCSI Knowledge Transfer consortium – an initiative supported by Knowledge Transfer Ireland and Enterprise Ireland. It is also held in partnership with MedTech Strategist who is holding their annual conference in Dublin from 25-27 April

Neil Gordon, TCD Startup Development Manager, said: “Trinity is Ireland’s leading university in terms of startup generation and is particularly successful in the medtech sector as well as in those of life sciences, ICT and engineering. This is a unique opportunity for 12 Irish medtech startups to meet with and engage Irish and international experts, mentors and investors. We wish all participants well, including Trinity spinouts, MitrAdapt treating complex heart valve disease and PLIO Surgical improving outcomes in gastrointestinal surgery.”

Professor Fergal O’Brien, Deputy Vice Chancellor for Research and Innovation at RCSI University of Medicine and Health Sciences said: “As a dedicated medicine and health sciences university, RCSI is improving human health through innovative translational medical research.  We are delighted to be partnering with MedTech Innovator and Trinity to host this event in order to foster high-potential life sciences spin-out companies that are making improvements in healthcare a reality for patients.

“We are looking forward to learning about the groundbreaking technology to support post-operative recovery in glaucoma patients by RCSI spin-out company LEP Biomedical, the innovative device for heart failure from Pumpinheart and device to repair tympanic membrane (eardrums) from TymPulse.”